Back to Search Start Over

[On the road to biological blood diagnosis of Alzheimer's disease?]

Authors :
Delaby C
Lehmann S
Source :
Medecine sciences : M/S [Med Sci (Paris)] 2024 Apr; Vol. 40 (4), pp. 351-360. Date of Electronic Publication: 2024 Apr 23.
Publication Year :
2024

Abstract

The growing number of people suffering from Alzheimer's disease (AD) represents a major public health problem. The diagnosis of AD is multidisciplinary and involves the use of amyloid and tau biomarkers measured in cerebrospinal fluid. Recent advances in analytical techniques now allow us to measure these biomarkers in blood. Blood biomarkers offer particularly promising potential for early, minimally invasive detection of AD, as well as for differential diagnosis of dementia and patient follow-up. The aim of this review is to provide an overview of current and candidate blood biomarkers for AD, their informative value, and their potential to be integrated into clinical practice in the near future.<br /> (© 2024 médecine/sciences – Inserm.)

Details

Language :
French
ISSN :
1958-5381
Volume :
40
Issue :
4
Database :
MEDLINE
Journal :
Medecine sciences : M/S
Publication Type :
Academic Journal
Accession number :
38651960
Full Text :
https://doi.org/10.1051/medsci/2024037